Study of Trimethoprim/Sulfamethoxazole as PCP Prophylaxis in CTD Patients

Status Recruiting

Clinical Trial Summary

Evaluation the efficacy and safety profile of trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia (PCP) prophylaxis in Patients With Connective Tissue Diseases (CTD) treated with high-dose glucocorticoids and immunosuppressive agents.

Open-labeled, randomized, prospective single-center clinical trial. Observation period of 12 weeks.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01747278
Study type	Interventional
Source	Peking Union Medical College Hospital
Contact	Hua Chen, MD
Phone	+86-10-69158797
Email	chenhua@pumch.cn
Status	Recruiting
Phase	Phase 2/Phase 3
Start date	August 2012
Completion date	August 2013

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04062578` - Effects Provided by a Physiotherapy Treatment Preventing Lower Extremity Injuries in Female Football Players	N/A
Not yet recruiting	`NCT04400019` - Prevention of COVID19 Infection in Nursing Homes by Chemoprophylaxis With Hydroxychloroquine (PREVICHARM)	Phase 2/Phase 3
Completed	`NCT00793455` - Outreach for Patients With Uncompleted Colorectal Cancer Screening Orders	N/A
Completed	`NCT00563264` - KAN-DO: A Family-based Intervention to Prevent Childhood Obesity	N/A
Completed	`NCT05261152` - S. Boulardii in Prevention of Antibiotic-associated Diarrhea in Hospitalized Adults With Respiratory Tract Infections	Phase 4
Completed	`NCT02165709` - Cohort Study of Risk Reducing Salpingectomy	N/A
Recruiting	`NCT06164600` - Bovine Colostrum for Prophylaxis Against Recurrent Urinary Tract Infection in Children	Phase 2
Completed	`NCT05365737` - Substantivity of Oral Rinses: Comparative Study	N/A
Completed	`NCT01776424` - Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease	Phase 3
Enrolling by invitation	`NCT02580279` - Study of Epigallocatechin-3-gallate (EGCG) for Skin Prevention in Patients With Breast Cancer Receiving Adjuvant Radiotherapy	Phase 2
Enrolling by invitation	`NCT02577393` - Study of Epigallocatechin-3-gallate (EGCG) for Esophagus Protection in Patients With Lung Cancer Receiving Radial Radiotherapy	Phase 2
Withdrawn	`NCT01137591` - Acetaminophen in Combination With N-Acetylcysteine (NAC) Versus Placebo in Treating Fever	N/A